v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities:    
Net loss $ (18,431) $ (16,013)
Net loss from discontinuing operations 6,053 1,427
Reconciliation of net loss to net cash used in operating activities, continuing operations:    
Stock-based compensation 865 825
Amortization of operating lease right-of-use assets 245 211
Depreciation and amortization expense 400 410
Change in fair value of share-settlement obligation derivative 250
Change in fair value of warrant liability (214)
Change in fair value of 2020 Convertible Note with fair value election 4
Accretion of debt discount 173
Loss on conversion of debt 2,518
Gain on sale of assets (14)
Changes in operating assets and liabilities net of impacts of business combination:    
Trade accounts and other receivables 51 (37)
Inventory 409 (66)
Prepaid expenses and other current assets (155) (469)
Accounts payable 156 (1,303)
Obligations under operating leases (193) (263)
Accrued expenses and other current liabilities 563 (756)
Net cash used in operating activities, continuing operations (10,037) (13,317)
Net cash used in operating activities, discontinuing operations (352) (673)
Net cash used in operating activities (10,389) (13,990)
Cash Flows from Investing Activities:    
Equipment purchases and leasehold improvements (608) (521)
Cash acquired from acquisition 30,163
Sale of Patent 50
Net cash (used in) provided by investing activities, continuing operations (608) 29,692
Net cash used in investing activities, discontinuing operations (76)
Net cash (used in) provided by investing activities (684) 29,692
Cash Flows from Financing Activities:    
Issuance of common stock (net of issuance costs) (246) 4
Issuance of Series C Preferred Stock, net of issuance costs 1,786
2020 Convertible Note proceeds 5,022
Principal payments on long-term debt (82)
Proceeds from lease financing 266
Principal payments on obligations under finance leases (131)
Net cash (used in) provided by financing activities, continuing operations (111) 6,730
Net cash used in financing activities, discontinuing operations (30) (21)
Net cash (used in) provided by financing activities (141) 6,709
Net (decrease) increase in cash and cash equivalents (11,214) 22,411
Cash and cash equivalents beginning of the period 20,608 792
Cash and cash equivalents end of the period 9,394 23,203
Supplemental disclosure of cash flow information from continuing operations:    
Cash paid for interest 25
Cash paid for income taxes 8
Non-cash investing activities from continuing operations:    
Fair value of non-cash merger consideration 59,920
Right-of-use asset obtained in exchange for new leases 1,189 83
Non-cash financing activities from continuing operations:    
Conversion of Preferred Stock to Common Stock upon Merger 30,793
Conversion of 2020 Convertible Notes and Accrued Interest to Common Stock upon Merger 16,190
Reclass warrant liability to equity upon Merger $ 421

Source